Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-18

FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Cosette Pharmaceuticals, Inc. for Ambien (zolpidem tartrate) under NDA 019908. The action relates to a modifica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambien (zolpidem)

Snippet

SUPPL AP for AMBIEN (ZOLPIDEM TARTRATE)